Back Dictionary Export CSV
Filter: Clear
ENCORE_PATIENT_ID MERGED_REGIMEN_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION BENCHMARK_GROUP LINK_NUMBER
20199648 20158122 1.65 41.8 03 2019-07-17 2019-07-22 EEF or EOF 02 N ETOPOSIDE + IFOSFAMIDE 100122884
20199729 20158123 1.88 82.2 null 2020-05-02 2020-05-31 DA 3+8 02 null COSMIC TRIAL 100995507
20200205 20158124 1.51 46.8 Neo-adjuvant (N) null 2018-07-05 Binimetinib + Encorafenib 2 N DARATUMUMAB 100355560
20200367 20158125 1.73 80.9 Adjuvant (A) 2016-07-15 2016-08-16 SOTORASIB 02 N EPIRUBICIN + FLUOROURACIL + OXALIPLATIN 101569823
20200379 20158126 1.58 105.8 Palliative (P) 2021-05-30 2021-10-21 Cisplatin +FU +Trastuzumab - Maint 02 N CAPECITABINE + CISPLATIN + STREPTOZOCIN 101544874
20200823 20158127 1.64 56.2 Palliative (P) 2018-09-02 2018-09-27 null 02 N ACTICCA-1 TRIAL 100337471
20201166 20158128 1.79 80.2 null 2018-05-09 2018-08-10 Pemigatinib 02 N EVEROLIMUS + LENVATINIB 100687744
20201314 20158129 1.75 94.6 Neo-adjuvant (N) 2017-12-01 2018-10-11 EEF or EOF 02 N BACILLUS CALMETTE-GUERIN 101256435
20201351 20158130 1.78 62 Curative (C) 2020-04-10 2020-04-11 CISPLATIN + FLUOROURACIL + Trastuzumab 02 N CARBOPLATIN + PEMETREXED 100065020
20201451 20158131 1.86 73 null 2021-11-15 2021-11-15 Nintedanib 01 null CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL 101639167
20201545 20158132 1.81 65 Palliative (P) 2020-11-10 2020-11-19 Doxorubicin 75mg/m2 02 Y PHITT F PLADO/SORAFENIB 100831795
20201595 20158133 1.57 83.1 03 2020-10-27 2020-10-30 SCOPE 2 TRIAL 02 N ECARBOX 100669388
20201779 20158134 1.8 95.5 Palliative (P) 2018-08-10 2018-08-10 EEF or EOF 02 N COSMIC TRIAL 100372276
20201824 20158135 1.84 50.4 Palliative (P) 2018-01-14 2018-09-19 EOF 02 N BORTEZOMIB + THALIDOMIDE 100763172
20202307 20158137 1.77 105.6 null 2015-02-04 2017-04-18 CEMIPLIMAB N null ECF 100270258
20202543 20158139 1.51 61.2 Palliative (P) 2018-01-20 2018-02-03 PACLITAXEL + RAMUCIRUMAB 02 N PEMETREXED 100765754
20202716 20158140 1.57 52.3 null 2021-02-14 2021-02-25 CHOP R - 21 days 2 N ECF 100129577
20203047 20158142 1.72 21.2 Palliative (P) 2019-08-30 2019-10-24 CAPE + OXALIPLATIN + TRASTUZUMAB 02 N CARBOPLATIN + LIPOSOMAL DOXORUBICIN 101847148
20203072 20158143 1.79 62.1 Palliative (P) 2021-08-05 2021-08-19 Cape+Cetuximab+Oxalip (2 wk) Maint 02 N CAPECITABINE + STREPTOZOCIN 100822352
20203204 20158144 1.71 79 null 2020-09-26 2020-09-26 Topotecan (oral) 02 null CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE 101602500
20203355 20158145 1.75 66.2 null 2017-12-04 2017-12-29 PHITT Trial 02 N CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE 101802754
20203480 20158146 1.89 55.1 Neo-adjuvant (N) null 2020-03-29 Fulvestrant + Palbociclib 99 N MIDOSTAURIN 101053316
20203627 20158147 1.58 72 null 2021-10-08 2021-10-08 Venetoclax 02 null TCX 101042890
20203679 20158148 1.82 68.3 null 2019-11-18 2019-12-19 Cisplatin + Radiotherapy 02 null IRINOTECAN + MDG + PANITUMUMAB 101039595
20203794 20158149 1.57 83.8 03 2017-09-25 2018-08-29 ETOPOSIDE 02 null GEMCITABINE + OXALIPLATIN 100679328
20203839 20158150 1.87 105.3 Palliative (P) null 2020-01-05 ECF null N IRINOTECAN + RALTITREXED 101501743
20203844 20158151 1.69 115.9 Palliative (P) 2020-12-18 2020-12-18 Bortezomib + MELPHALAN N Y CARBOPLATIN + CYCLOPHOSPHAMIDE + DOXORUBICIN + PACLITAXEL 100156914
20203961 20158152 1.81 56 null 2019-11-28 2019-12-07 POMALIDOMIDE 02 null BORTEZOMIB + DARATUMUMAB 100699246
20204002 20158153 1.65 56.8 null 2019-11-21 2019-12-26 CAV null N CISPLATIN + FLUOROURACIL + RT 101176113
20204109 20158155 1.65 101.8 Curative (C) 2019-05-25 2019-05-25 FCarboSt 02 N CAPE + OXALIPLATIN + TRASTUZUMAB 100726984
20204380 20158156 1.71 44.1 Neo-adjuvant (N) 2017-12-04 2019-09-15 Carboplatin + Vinorelbine Oral null null INTERAACT TRIAL 100099922
20204408 20158157 1.8 62.8 03 2017-08-01 2018-02-04 PACLITAXEL + RAMUCIRUMAB null N IPILIMUMAB 101403143
20204423 20158158 1.65 83.3 Palliative (P) 2021-04-06 2021-04-06 FOXTROT TRIAL N null CISPLATIN + RALTITREXED + TRASTUZUMAB 100383333
20204466 20158160 1.61 89.5 Curative (C) 2018-08-24 2018-08-31 Gemcitabine + Oxaliplatin 01 null CABAZITAXEL 101045666
20204510 20158161 1.72 86.6 Palliative (P) 2020-06-15 2020-08-01 SCOPE 2 TRIAL N null COSMIC TRIAL 101478155
20204742 20158162 1.8 63 null 2018-05-05 2018-05-20 null 02 Y ECARBOX 100327205
20204955 20158163 1.75 57.5 Adjuvant (A) 2021-04-09 2021-04-10 Cladribine IV weekly 02 null BEVACIZUMAB + FLUOROURACIL + IRINOTECAN 100856300
20205115 20158164 1.8 75 null 2018-06-18 2018-07-09 Rucaparib 02 null CARBOPLATIN + DOCETAXEL + TRASTUZUMAB 101497520
20205252 20158165 1.54 63 Curative (C) 2021-04-04 2021-04-09 Lomustine N null PEMETREXED 101853630
20205393 20158166 1.6 58.2 Curative (C) 2019-10-21 2019-11-11 Bevacizumab + Irinotecan + MdG 02 N AFATINIB 100502456
20205425 20158167 1.77 65.6 Palliative (P) 2016-09-01 2016-09-01 Etoposide + Ifosfamide (5 days) N N CAV 101035569
20205674 20158168 1.55 79.7 Curative (C) 2018-10-27 2018-11-29 IBRUTINIB 02 N DOXORUBICIN 101791858
20205748 20158169 1.77 96 null 2016-09-23 2017-11-18 EEF or EOF 02 null PHITT C SIOPEL-3HR 100908183
20205829 20158171 1.97 88.4 null 2019-01-11 2019-01-11 CARBOPLATIN + GEMCITABINE 02 N AFLIBERCEPT + IRINOTECAN + OXALIPLATIN + MDG 101085882
20206048 20158173 1.81 77.6 Palliative (P) 2019-10-19 2019-10-19 AFATINIB 02 N BEVACIZUMAB + CAPECITABINE + OXALIPLATIN 101257517
20206119 20158174 1.75 78 null 2017-12-02 2018-01-06 Carboplatin + Fluorouracil + Streptozocin 02 null IRINOTECAN + RALTITREXED 100637538
20206443 20158175 1.81 80.7 Curative (C) 2018-11-15 2018-12-05 ECF 02 N PEMETREXED 101450822
20206480 20158176 1.69 77.1 null 2018-04-03 2018-04-03 Hydroxycarbamide N null TRABECTEDIN 100364677
20206498 20158177 1.75 78.9 null 2018-02-12 2018-09-14 OXALIPLATIN + MDG + PANITUMUMAB 02 null LETROZOLE + RIBOCICLIB 101349727
20206530 20158178 1.71 94.5 null 2019-02-15 2019-03-21 ISATUXIMAB + POMALIDOMIDE 02 null CARBOPLATIN + VINORELBINE 101395576